60 Degrees Pharmaceuticals, Inc. (SXTP) Stock Statistics & Valuation Metrics

60 Degrees Pharmaceuticals, Inc. has a market cap or net worth of $3.31M. The enterprise value is $13.28M.

Market Cap

$3.31M

Enterprise Value

$13.28M

60 Degrees Pharmaceuticals, Inc. has 3,516,988 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

3,516,988

Owned by Insiders

0.69%

Owned by Institutions

11.53%

60 Degrees Pharmaceuticals, Inc.’s return on equity (ROE) is -2.13 and return on invested capital (ROIC) is -219.65%.

Return on Equity (ROE)

-2.13

Return on Assets (ROA)

-1.37

Return on Invested Capital (ROIC)

-219.65%

Return on Capital Employed (ROCE)

-2.20

Revenue Per Employee

335.16K

Profits Per Employee

-2.46M

Employee Count

3

Asset Turnover

0.19

Inventory Turnover

1.19

The current PE Ratio of 60 Degrees Pharmaceuticals, Inc. is -0.17. 60 Degrees Pharmaceuticals, Inc.’s PEG ratio is -0.00.

PE Ratio

-0.17

PS Ratio

3.20

PB Ratio

1.03

Price to FCF

-0.40

Price to Operating Cash Flow

-0.31

PEG Ratio

-0.00

In the last 12 months, 60 Degrees Pharmaceuticals, Inc. had revenue of 1.01M and earned -7.37M in profits. Earnings per share was -11.73.

Revenue

1.01M

Gross Profit

223.78K

Operating Income

-7.76M

Pretax Income

-7.37M

Net Income

-7.37M

EBITDA

-7.28M

Earnings Per Share (EPS)

-11.73

In the last 12 months, operating cash flow was -8.77M and capital expenditures -175,429, giving a free cash flow of -8.95M billion.

Operating Cash Flow

-8.77M

Free Cash Flow

-8.95M

Free Cash Flow per Share

-3.37

60 Degrees Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-257.16%

Earnings Yield

-308.91%

Beta

1.96

52-Week Price Change

-81.16%

50-Day Moving Average

1.01

200-Day Moving Average

1.77

Relative Strength Index (RSI)

46.06

Average Volume (3m)

400.48K

60 Degrees Pharmaceuticals, Inc. upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

Nov 12, 2026

Ex-Dividend Date

―

60 Degrees Pharmaceuticals, Inc. as a current ratio of 2.66, with Debt / Equity ratio of 4.41%

Current Ratio

2.66

Quick Ratio

2.30

Debt to Market Cap

0.11

Net Debt to EBITDA

0.19

Interest Coverage Ratio

-994.05

In the past 12 months, 60 Degrees Pharmaceuticals, Inc. has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

60 Degrees Pharmaceuticals, Inc. EV to EBITDA ratio is -0.33, with an EV/FCF ratio of -0.29.

EV to Sales

2.35

EV to EBITDA

-0.33

EV to Free Cash Flow

-0.29

EV to Operating Cash Flow

-0.30

60 Degrees Pharmaceuticals, Inc. has $1.02M in cash and marketable securities with $151.18K in debt, giving a net cash position of $871.43K billion.

Cash & Marketable Securities

$1.02M

Total Debt

$151.18K

Net Cash

$871.43K

Net Cash Per Share

$0.25

Tangible Book Value Per Share

$0.84

Gross margin is 19.42%, with operating margin of -774.90%, and net profit margin of -730.23%.

Gross Margin

19.42%

Operating Margin

-774.90%

Pretax Margin

-730.29%

Net Profit Margin

-730.23%

EBITDA Margin

-720.89%

EBIT Margin

-730.17%

The average price target for 60 Degrees Pharmaceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

―

Price Target Upside

―

Analyst Consensus

Neutral

Analyst Count

1

Revenue Growth Forecast

24.77%

EPS Growth Forecast

86.32%

Smart Score

―

AI Score

43